| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.908 | 0.004 | 0.908 | Amyloid beta aggregation inhibitor | 0.908 0.004 DBMET01640 | ||
| 0.854 | 0.004 | 0.854 | Free radical scavenger | 0.854 0.004 DBMET01640 | ||
| 0.851 | 0.011 | 0.851 | Apoptosis agonist | 0.851 0.011 DBMET01640 | ||
| 0.804 | 0.004 | 0.804 | Antioxidant | 0.804 0.004 DBMET01640 | ||
| 0.8 | 0.003 | 0.8 | Superoxide dismutase inhibitor | 0.8 0.003 DBMET01640 | ||
| 0.8 | 0.011 | 0.8 | Caspase 9 stimulant | 0.8 0.011 DBMET01640 | ||
| 0.789 | 0.014 | 0.789 | Transcription factor NF kappa B inhibitor | 0.789 0.014 DBMET01640 | ||
| 0.755 | 0.005 | 0.755 | Lipoxygenase inhibitor | 0.755 0.005 DBMET01640 | ||
| 0.706 | 0.005 | 0.706 | Antiamyloidogenic | 0.706 0.005 DBMET01640 | ||
| 0.709 | 0.029 | 0.709 | Antiinflammatory | 0.709 0.029 DBMET01640 | ||
| 0.655 | 0.004 | 0.655 | Monophenol monooxygenase inhibitor | 0.655 0.004 DBMET01640 | ||
| 0.635 | 0.004 | 0.635 | P-glycoprotein inhibitor | 0.635 0.004 DBMET01640 | ||
| 0.632 | 0.003 | 0.632 | DNA methyltransferase I inhibitor | 0.632 0.003 DBMET01640 | ||
| 0.621 | 0.003 | 0.621 | HIV-1 integrase (3'-Processing) inhibitor | 0.621 0.003 DBMET01640 | ||
| 0.632 | 0.015 | 0.632 | Aldehyde oxidase inhibitor | 0.632 0.015 DBMET01640 | ||
| 0.61 | 0.003 | 0.61 | Topoisomerase II alpha inhibitor | 0.61 0.003 DBMET01640 | ||
| 0.605 | 0.004 | 0.605 | DNA methylase inhibitor | 0.605 0.004 DBMET01640 | ||
| 0.592 | 0.003 | 0.592 | HIV-1 integrase (Strand Transfer) inhibitor | 0.592 0.003 DBMET01640 | ||
| 0.563 | 0.016 | 0.563 | 12-Lipoxygenase inhibitor | 0.563 0.016 DBMET01640 | ||
| 0.536 | 0.002 | 0.536 | Vanilloid 1 agonist | 0.536 0.002 DBMET01640 | ||
| 0.53 | 0.005 | 0.53 | Transcription factor STAT3 inhibitor | 0.53 0.005 DBMET01640 | ||
| 0.516 | 0.007 | 0.516 | Transcription factor STAT inhibitor | 0.516 0.007 DBMET01640 | ||
| 0.509 | 0.015 | 0.509 | Nitric oxide antagonist | 0.509 0.015 DBMET01640 | ||
| 0.498 | 0.007 | 0.498 | Topoisomerase II inhibitor | 0.498 0.007 DBMET01640 | ||
| 0.491 | 0.001 | 0.491 | Glucose-6-phosphate translocase inhibitor | 0.491 0.001 DBMET01640 | ||
| 0.502 | 0.02 | 0.502 | Apoptosis antagonist | 0.502 0.02 DBMET01640 | ||
| 0.476 | 0.008 | 0.476 | Melanin inhibitor | 0.476 0.008 DBMET01640 | ||
| 0.473 | 0.009 | 0.473 | Tubulin antagonist | 0.473 0.009 DBMET01640 | ||
| 0.483 | 0.031 | 0.483 | Vasodilator, peripheral | 0.483 0.031 DBMET01640 | ||
| 0.438 | 0.004 | 0.438 | Vanilloid agonist | 0.438 0.004 DBMET01640 | ||
| 0.427 | 0.004 | 0.427 | Succinate dehydrogenase inhibitor | 0.427 0.004 DBMET01640 | ||
| 0.457 | 0.038 | 0.457 | Angiogenesis inhibitor | 0.457 0.038 DBMET01640 | ||
| 0.432 | 0.022 | 0.432 | Tumour necrosis factor alpha release inhibitor | 0.432 0.022 DBMET01640 | ||
| 0.41 | 0.003 | 0.41 | HIV-1 integrase inhibitor | 0.41 0.003 DBMET01640 | ||
| 0.434 | 0.034 | 0.434 | Caspase 3 stimulant | 0.434 0.034 DBMET01640 | ||
| 0.402 | 0.005 | 0.402 | 5-Lipoxygenase inhibitor | 0.402 0.005 DBMET01640 | ||
| 0.398 | 0.007 | 0.398 | Cyclooxygenase 1 inhibitor | 0.398 0.007 DBMET01640 | ||
| 0.391 | 0.003 | 0.391 | Transcription factor AP-1 inhibitor | 0.391 0.003 DBMET01640 | ||
| 0.423 | 0.045 | 0.423 | Cholesterol antagonist | 0.423 0.045 DBMET01640 | ||
| 0.383 | 0.005 | 0.383 | Histone acetyltransferase inhibitor | 0.383 0.005 DBMET01640 | ||
| 0.384 | 0.01 | 0.384 | Lipid peroxidase inhibitor | 0.384 0.01 DBMET01640 | ||
| 0.377 | 0.004 | 0.377 | Carbonic anhydrase VI inhibitor | 0.377 0.004 DBMET01640 | ||
| 0.425 | 0.054 | 0.425 | Immunosuppressant | 0.425 0.054 DBMET01640 | ||
| 0.4 | 0.03 | 0.4 | Hypoxia-inducible factor 1 alpha inhibitor | 0.4 0.03 DBMET01640 | ||
| 0.38 | 0.015 | 0.38 | Hepatoprotectant | 0.38 0.015 DBMET01640 | ||
| 0.409 | 0.044 | 0.409 | 5 Hydroxytryptamine release stimulant | 0.409 0.044 DBMET01640 | ||
| 0.37 | 0.007 | 0.37 | Interleukin 1 antagonist | 0.37 0.007 DBMET01640 | ||
| 0.366 | 0.012 | 0.366 | Amylase inhibitor | 0.366 0.012 DBMET01640 | ||
| 0.446 | 0.092 | 0.446 | Transcription factor inhibitor | 0.446 0.092 DBMET01640 | ||
| 0.415 | 0.068 | 0.415 | Histamine release inhibitor | 0.415 0.068 DBMET01640 | ||
| 0.355 | 0.015 | 0.355 | Tyrosine 3 hydroxylase inhibitor | 0.355 0.015 DBMET01640 | ||
| 0.341 | 0.004 | 0.341 | Keratolytic | 0.341 0.004 DBMET01640 | ||
| 0.343 | 0.008 | 0.343 | Chelator | 0.343 0.008 DBMET01640 | ||
| 0.363 | 0.029 | 0.363 | Antimitotic | 0.363 0.029 DBMET01640 | ||
| 0.404 | 0.073 | 0.404 | 15-Lipoxygenase inhibitor | 0.404 0.073 DBMET01640 | ||
| 0.339 | 0.007 | 0.339 | Cystathionine beta-synthase inhibitor | 0.339 0.007 DBMET01640 | ||
| 0.332 | 0.006 | 0.332 | Xanthine oxidase inhibitor | 0.332 0.006 DBMET01640 | ||
| 0.33 | 0.005 | 0.33 | Carbonic anhydrase XIII inhibitor | 0.33 0.005 DBMET01640 | ||
| 0.349 | 0.026 | 0.349 | 5 Hydroxytryptamine uptake stimulant | 0.349 0.026 DBMET01640 | ||
| 0.346 | 0.031 | 0.346 | Sigma receptor agonist | 0.346 0.031 DBMET01640 | ||
| 0.361 | 0.05 | 0.361 | Vasodilator, coronary | 0.361 0.05 DBMET01640 | ||
| 0.316 | 0.008 | 0.316 | Interleukin 1b antagonist | 0.316 0.008 DBMET01640 | ||
| 0.352 | 0.048 | 0.352 | Calcium channel activator | 0.352 0.048 DBMET01640 | ||
| 0.313 | 0.015 | 0.313 | Protein kinase stimulant | 0.313 0.015 DBMET01640 | ||
| 0.382 | 0.085 | 0.382 | Antibacterial | 0.382 0.085 DBMET01640 | ||
| 0.327 | 0.032 | 0.327 | Peroxidase inhibitor | 0.327 0.032 DBMET01640 | ||
| 0.298 | 0.005 | 0.298 | Carbonic anhydrase III inhibitor | 0.298 0.005 DBMET01640 | ||
| 0.33 | 0.043 | 0.33 | Hypoglycemic | 0.33 0.043 DBMET01640 | ||
| 0.304 | 0.02 | 0.304 | MAO inhibitor | 0.304 0.02 DBMET01640 | ||
| 0.282 | 0.009 | 0.282 | Carbonic anhydrase XV inhibitor | 0.282 0.009 DBMET01640 | ||
| 0.289 | 0.016 | 0.289 | MAO A inhibitor | 0.289 0.016 DBMET01640 | ||
| 0.268 | 0.004 | 0.268 | HIV-1 integrase (Overall Integration) inhibitor | 0.268 0.004 DBMET01640 | ||
| 0.281 | 0.02 | 0.281 | Phospholipase C inhibitor | 0.281 0.02 DBMET01640 | ||
| 0.273 | 0.014 | 0.273 | DNA polymerase I inhibitor | 0.273 0.014 DBMET01640 | ||
| 0.269 | 0.011 | 0.269 | Toll-Like receptor antagonist | 0.269 0.011 DBMET01640 | ||
| 0.27 | 0.017 | 0.27 | Toll-Like receptor 9 antagonist | 0.27 0.017 DBMET01640 | ||
| 0.28 | 0.027 | 0.28 | Thrombolytic | 0.28 0.027 DBMET01640 | ||
| 0.267 | 0.015 | 0.267 | MAO B inhibitor | 0.267 0.015 DBMET01640 | ||
| 0.299 | 0.048 | 0.299 | Pyruvate kinase inhibitor | 0.299 0.048 DBMET01640 | ||
| 0.262 | 0.018 | 0.262 | M18 aspartyl aminopeptidase inhibitor | 0.262 0.018 DBMET01640 | ||
| 0.296 | 0.061 | 0.296 | Insulysin inhibitor | 0.296 0.061 DBMET01640 | ||
| 0.252 | 0.017 | 0.252 | Cholesterol synthesis inhibitor | 0.252 0.017 DBMET01640 | ||
| 0.284 | 0.051 | 0.284 | Interleukin antagonist | 0.284 0.051 DBMET01640 | ||
| 0.255 | 0.025 | 0.255 | Cyclooxygenase inhibitor | 0.255 0.025 DBMET01640 | ||
| 0.233 | 0.005 | 0.233 | Thioredoxin inhibitor | 0.233 0.005 DBMET01640 | ||
| 0.258 | 0.034 | 0.258 | Neurotrophic factor enhancer | 0.258 0.034 DBMET01640 | ||
| 0.232 | 0.013 | 0.232 | Toll-Like receptor 2 antagonist | 0.232 0.013 DBMET01640 | ||
| 0.228 | 0.011 | 0.228 | Breast cancer-resistant protein inhibitor | 0.228 0.011 DBMET01640 | ||
| 0.255 | 0.04 | 0.255 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.255 0.04 DBMET01640 | ||
| 0.222 | 0.007 | 0.222 | TRPA1 agonist | 0.222 0.007 DBMET01640 | ||
| 0.283 | 0.069 | 0.283 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | 0.283 0.069 DBMET01640 | ||
| 0.232 | 0.019 | 0.232 | ATPase inhibitor | 0.232 0.019 DBMET01640 | ||
| 0.243 | 0.03 | 0.243 | Interferon gamma antagonist | 0.243 0.03 DBMET01640 | ||
| 0.257 | 0.047 | 0.257 | Anesthetic general | 0.257 0.047 DBMET01640 | ||
| 0.237 | 0.029 | 0.237 | NOS3 expression enhancer | 0.237 0.029 DBMET01640 | ||
| 0.212 | 0.007 | 0.212 | Beta tubulin antagonist | 0.212 0.007 DBMET01640 | ||
| 0.206 | 0.013 | 0.206 | DNA directed RNA polymerase inhibitor | 0.206 0.013 DBMET01640 | ||
| 0.206 | 0.015 | 0.206 | Beta amyloid protein antagonist | 0.206 0.015 DBMET01640 | ||
| 0.199 | 0.009 | 0.199 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.199 0.009 DBMET01640 | ||
| 0.194 | 0.005 | 0.194 | Phosphodiesterase 6D inhibitor | 0.194 0.005 DBMET01640 | ||
| 0.19 | 0.005 | 0.19 | Estradiol 17 beta-dehydrogenase inhibitor | 0.19 0.005 DBMET01640 | ||
| 0.202 | 0.02 | 0.202 | Expectorant | 0.202 0.02 DBMET01640 | ||
| 0.245 | 0.066 | 0.245 | Cyclic AMP phosphodiesterase inhibitor | 0.245 0.066 DBMET01640 | ||
| 0.194 | 0.016 | 0.194 | Adenylate cyclase stimulant | 0.194 0.016 DBMET01640 | ||
| 0.263 | 0.086 | 0.263 | Spasmolytic | 0.263 0.086 DBMET01640 | ||
| 0.249 | 0.076 | 0.249 | 5 Hydroxytryptamine 1E antagonist | 0.249 0.076 DBMET01640 | ||
| 0.226 | 0.053 | 0.226 | Nitric-oxide synthase stimulant | 0.226 0.053 DBMET01640 | ||
| 0.179 | 0.007 | 0.179 | Alpha tubulin antagonist | 0.179 0.007 DBMET01640 | ||
| 0.205 | 0.035 | 0.205 | Heat shock protein 90 antagonist | 0.205 0.035 DBMET01640 | ||
| 0.199 | 0.031 | 0.199 | Cyclooxygenase 2 inhibitor | 0.199 0.031 DBMET01640 | ||
| 0.178 | 0.011 | 0.178 | HIV-1 reverse transcriptase inhibitor | 0.178 0.011 DBMET01640 | ||
| 0.214 | 0.049 | 0.214 | Amyloid beta precursor protein antagonist | 0.214 0.049 DBMET01640 | ||
| 0.177 | 0.013 | 0.177 | Heat shock protein 70 antagonist | 0.177 0.013 DBMET01640 | ||
| 0.245 | 0.082 | 0.245 | Interleukin agonist | 0.245 0.082 DBMET01640 | ||
| 0.21 | 0.048 | 0.21 | Tumour necrosis factor antagonist | 0.21 0.048 DBMET01640 | ||
| 0.174 | 0.011 | 0.174 | Toll-Like receptor 4 antagonist | 0.174 0.011 DBMET01640 | ||
| 0.198 | 0.035 | 0.198 | Arachidonic acid antagonist | 0.198 0.035 DBMET01640 | ||
| 0.172 | 0.01 | 0.172 | Carbonic anhydrase V inhibitor | 0.172 0.01 DBMET01640 | ||
| 0.218 | 0.058 | 0.218 | Non-steroidal antiinflammatory agent | 0.218 0.058 DBMET01640 | ||
| 0.194 | 0.035 | 0.194 | Acetylcholinesterase inhibitor | 0.194 0.035 DBMET01640 | ||
| 0.163 | 0.005 | 0.163 | Plasminogen activator inhibitor antagonist | 0.163 0.005 DBMET01640 | ||
| 0.236 | 0.078 | 0.236 | Vasodilator | 0.236 0.078 DBMET01640 | ||
| 0.191 | 0.037 | 0.191 | Alkaline phosphatase inhibitor | 0.191 0.037 DBMET01640 | ||
| 0.225 | 0.071 | 0.225 | Peptidyltransferase inhibitor | 0.225 0.071 DBMET01640 | ||
| 0.196 | 0.045 | 0.196 | Phospholipase A2 inhibitor | 0.196 0.045 DBMET01640 | ||
| 0.159 | 0.009 | 0.159 | Ornithine decarboxylase inhibitor | 0.159 0.009 DBMET01640 | ||
| 0.265 | 0.115 | 0.265 | Antithrombotic | 0.265 0.115 DBMET01640 | ||
| 0.17 | 0.022 | 0.17 | Mucolytic | 0.17 0.022 DBMET01640 | ||
| 0.172 | 0.025 | 0.172 | Pregnane X receptor agonist | 0.172 0.025 DBMET01640 | ||
| 0.162 | 0.016 | 0.162 | DOPA decarboxylase inhibitor | 0.162 0.016 DBMET01640 | ||
| 0.179 | 0.034 | 0.179 | Aldehyde dehydrogenase inhibitor | 0.179 0.034 DBMET01640 | ||
| 0.163 | 0.017 | 0.163 | Histidine decarboxylase inhibitor | 0.163 0.017 DBMET01640 | ||
| 0.153 | 0.009 | 0.153 | Thioredoxin reductase inhibitor | 0.153 0.009 DBMET01640 | ||
| 0.225 | 0.082 | 0.225 | Angiogenesis stimulant | 0.225 0.082 DBMET01640 | ||
| 0.165 | 0.022 | 0.165 | Sphingosine 1-phosphate receptor 4 antagonist | 0.165 0.022 DBMET01640 | ||
| 0.153 | 0.01 | 0.153 | Carbonic anhydrase VA inhibitor | 0.153 0.01 DBMET01640 | ||
| 0.157 | 0.019 | 0.157 | Telomerase inhibitor | 0.157 0.019 DBMET01640 | ||
| 0.158 | 0.022 | 0.158 | Beta glucuronidase inhibitor | 0.158 0.022 DBMET01640 | ||
| 0.203 | 0.07 | 0.203 | Platelet adhesion inhibitor | 0.203 0.07 DBMET01640 | ||
| 0.155 | 0.025 | 0.155 | Catalase inhibitor | 0.155 0.025 DBMET01640 | ||
| 0.151 | 0.02 | 0.151 | Electron transport complex I inhibitor | 0.151 0.02 DBMET01640 | ||
| 0.167 | 0.037 | 0.167 | Proteasome inhibitor | 0.167 0.037 DBMET01640 | ||
| 0.161 | 0.032 | 0.161 | Microtubule formation inhibitor | 0.161 0.032 DBMET01640 | ||
| 0.137 | 0.009 | 0.137 | Sirtuin 1 inhibitor | 0.137 0.009 DBMET01640 | ||
| 0.142 | 0.015 | 0.142 | Glutamate decarboxylase inhibitor | 0.142 0.015 DBMET01640 | ||
| 0.198 | 0.075 | 0.198 | Insulin sensitizer | 0.198 0.075 DBMET01640 | ||
| 0.131 | 0.009 | 0.131 | Phosphodiesterase VI inhibitor | 0.131 0.009 DBMET01640 | ||
| 0.135 | 0.014 | 0.135 | Myeloperoxidase inhibitor | 0.135 0.014 DBMET01640 | ||
| 0.154 | 0.033 | 0.154 | Ca2+-transporting ATPase inhibitor | 0.154 0.033 DBMET01640 | ||
| 0.208 | 0.088 | 0.208 | Hypolipemic | 0.208 0.088 DBMET01640 | ||
| 0.152 | 0.032 | 0.152 | Papain-like protease (SARS coronavirus) inhibitor | 0.152 0.032 DBMET01640 | ||
| 0.181 | 0.062 | 0.181 | Heat shock protein 90 alpha antagonist | 0.181 0.062 DBMET01640 | ||
| 0.132 | 0.013 | 0.132 | ATPase (Vacuolar H+) inhibitor | 0.132 0.013 DBMET01640 | ||
| 0.261 | 0.145 | 0.261 | GABA C receptor rho-3 antagonist | 0.261 0.145 DBMET01640 | ||
| 0.17 | 0.054 | 0.17 | Thiol protease inhibitor | 0.17 0.054 DBMET01640 | ||
| 0.247 | 0.131 | 0.247 | Sodium/bile acid cotransporter inhibitor | 0.247 0.131 DBMET01640 | ||
| 0.126 | 0.011 | 0.126 | Carbonic anhydrase VB inhibitor | 0.126 0.011 DBMET01640 | ||
| 0.134 | 0.02 | 0.134 | Macrophage migration inhibitory factor inhibitor | 0.134 0.02 DBMET01640 | ||
| 0.29 | 0.177 | 0.29 | 5 Hydroxytryptamine release inhibitor | 0.29 0.177 DBMET01640 | ||
| 0.156 | 0.044 | 0.156 | Interleukin 4 antagonist | 0.156 0.044 DBMET01640 | ||
| 0.22 | 0.109 | 0.22 | Immunostimulant | 0.22 0.109 DBMET01640 | ||
| 0.146 | 0.035 | 0.146 | Butyrylcholinesterase inhibitor | 0.146 0.035 DBMET01640 | ||
| 0.123 | 0.014 | 0.123 | Granulocyte macrophage colony stimulating factor agonist | 0.123 0.014 DBMET01640 | ||
| 0.11 | 0.004 | 0.11 | Factor III inhibitor | 0.11 0.004 DBMET01640 | ||
| 0.112 | 0.008 | 0.112 | Carbonic anhydrase XIV inhibitor | 0.112 0.008 DBMET01640 | ||
| 0.208 | 0.109 | 0.208 | DNA damaging | 0.208 0.109 DBMET01640 | ||
| 0.133 | 0.035 | 0.133 | Estrogen antagonist | 0.133 0.035 DBMET01640 | ||
| 0.165 | 0.069 | 0.165 | Neurotensin receptor agonist | 0.165 0.069 DBMET01640 | ||
| 0.146 | 0.051 | 0.146 | Cyclooxygenase 3 inhibitor | 0.146 0.051 DBMET01640 | ||
| 0.112 | 0.02 | 0.112 | GABA aminotransferase inhibitor | 0.112 0.02 DBMET01640 | ||
| 0.101 | 0.01 | 0.101 | Leukotriene B4 antagonist | 0.101 0.01 DBMET01640 | ||
| 0.105 | 0.019 | 0.105 | Estrogen-related receptor beta agonist | 0.105 0.019 DBMET01640 | ||
| 0.125 | 0.04 | 0.125 | Acetylcholine release stimulant | 0.125 0.04 DBMET01640 | ||
| 0.121 | 0.037 | 0.121 | Prolactin inhibitor | 0.121 0.037 DBMET01640 | ||
| 0.188 | 0.104 | 0.188 | ErbB-1 antagonist | 0.188 0.104 DBMET01640 | ||
| 0.119 | 0.036 | 0.119 | Calcium antagonist | 0.119 0.036 DBMET01640 | ||
| 0.091 | 0.01 | 0.091 | Transcription factor RelA inhibitor | 0.091 0.01 DBMET01640 | ||
| 0.145 | 0.064 | 0.145 | Neurotrophic factor | 0.145 0.064 DBMET01640 | ||
| 0.098 | 0.018 | 0.098 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.098 0.018 DBMET01640 | ||
| 0.137 | 0.057 | 0.137 | Cathepsin H inhibitor | 0.137 0.057 DBMET01640 | ||
| 0.1 | 0.022 | 0.1 | Leukotriene antagonist | 0.1 0.022 DBMET01640 | ||
| 0.115 | 0.039 | 0.115 | Estrogen receptor beta antagonist | 0.115 0.039 DBMET01640 | ||
| 0.118 | 0.043 | 0.118 | Sphingomyelinase inhibitor | 0.118 0.043 DBMET01640 | ||
| 0.095 | 0.02 | 0.095 | GABA B receptor agonist | 0.095 0.02 DBMET01640 | ||
| 0.079 | 0.005 | 0.079 | Catechol O-methyltransferase inhibitor | 0.079 0.005 DBMET01640 | ||
| 0.151 | 0.077 | 0.151 | Protein-tyrosine phosphatase inhibitor | 0.151 0.077 DBMET01640 | ||
| 0.12 | 0.047 | 0.12 | Mediator release inhibitor | 0.12 0.047 DBMET01640 | ||
| 0.08 | 0.009 | 0.08 | Vanilloid 2 antagonist | 0.08 0.009 DBMET01640 | ||
| 0.093 | 0.023 | 0.093 | Secretase beta inhibitor | 0.093 0.023 DBMET01640 | ||
| 0.076 | 0.006 | 0.076 | Sirtuin 2 inhibitor | 0.076 0.006 DBMET01640 | ||
| 0.115 | 0.048 | 0.115 | Bronchodilator | 0.115 0.048 DBMET01640 | ||
| 0.102 | 0.035 | 0.102 | Glutathione S-transferase inhibitor | 0.102 0.035 DBMET01640 | ||
| 0.118 | 0.051 | 0.118 | GABA C receptor agonist | 0.118 0.051 DBMET01640 | ||
| 0.096 | 0.03 | 0.096 | Estrogen receptor alpha antagonist | 0.096 0.03 DBMET01640 | ||
| 0.093 | 0.029 | 0.093 | Phenylalanine 4-hydroxylase inhibitor | 0.093 0.029 DBMET01640 | ||
| 0.12 | 0.057 | 0.12 | Photosensitizer | 0.12 0.057 DBMET01640 | ||
| 0.116 | 0.053 | 0.116 | AMP-activated protein kinase stimulant | 0.116 0.053 DBMET01640 | ||
| 0.074 | 0.011 | 0.074 | Leukotriene C antagonist | 0.074 0.011 DBMET01640 | ||
| 0.079 | 0.016 | 0.079 | Heme oxygenase stimulant | 0.079 0.016 DBMET01640 | ||
| 0.099 | 0.037 | 0.099 | Inducible nitric-oxide synthase inhibitor | 0.099 0.037 DBMET01640 | ||
| 0.083 | 0.023 | 0.083 | Xanthine dehydrogenase inhibitor | 0.083 0.023 DBMET01640 | ||
| 0.066 | 0.007 | 0.066 | Estradiol 17 beta-dehydrogenase 3 inhibitor | 0.066 0.007 DBMET01640 | ||
| 0.184 | 0.126 | 0.184 | RNA-directed DNA polymerase inhibitor | 0.184 0.126 DBMET01640 | ||
| 0.072 | 0.015 | 0.072 | Carbonic anhydrase VII inhibitor | 0.072 0.015 DBMET01640 | ||
| 0.136 | 0.079 | 0.136 | Mannose-6-phosphate isomerase inhibitor | 0.136 0.079 DBMET01640 | ||
| 0.246 | 0.19 | 0.246 | Alpha-glucosidase inhibitor | 0.246 0.19 DBMET01640 | ||
| 0.08 | 0.023 | 0.08 | Aldose reductase inhibitor | 0.08 0.023 DBMET01640 | ||
| 0.108 | 0.052 | 0.108 | Anabolic | 0.108 0.052 DBMET01640 | ||
| 0.11 | 0.056 | 0.11 | Urease inhibitor | 0.11 0.056 DBMET01640 | ||
| 0.141 | 0.087 | 0.141 | GABA C receptor rho-2 antagonist | 0.141 0.087 DBMET01640 | ||
| 0.116 | 0.066 | 0.116 | Protein-tyrosine phosphatase 1B inhibitor | 0.116 0.066 DBMET01640 | ||
| 0.059 | 0.011 | 0.059 | Estradiol 17 beta-dehydrogenase 2 inhibitor | 0.059 0.011 DBMET01640 | ||
| 0.064 | 0.018 | 0.064 | Squalene epoxidase inhibitor | 0.064 0.018 DBMET01640 | ||
| 0.102 | 0.057 | 0.102 | Creatine kinase inhibitor | 0.102 0.057 DBMET01640 | ||
| 0.054 | 0.01 | 0.054 | Kainate receptor agonist | 0.054 0.01 DBMET01640 | ||
| 0.135 | 0.091 | 0.135 | Cholinergic | 0.135 0.091 DBMET01640 | ||
| 0.057 | 0.013 | 0.057 | Dopamine D5 agonist | 0.057 0.013 DBMET01640 | ||
| 0.073 | 0.031 | 0.073 | Neuraminidase inhibitor | 0.073 0.031 DBMET01640 | ||
| 0.064 | 0.023 | 0.064 | Pregnane X receptor antagonist | 0.064 0.023 DBMET01640 | ||
| 0.167 | 0.128 | 0.167 | Platelet antagonist | 0.167 0.128 DBMET01640 | ||
| 0.064 | 0.028 | 0.064 | Ryanodine receptor antagonist | 0.064 0.028 DBMET01640 | ||
| 0.048 | 0.012 | 0.048 | Leukotriene C4 antagonist | 0.048 0.012 DBMET01640 | ||
| 0.094 | 0.06 | 0.094 | Uric acid excretion stimulant | 0.094 0.06 DBMET01640 | ||
| 0.059 | 0.027 | 0.059 | Aconitate hydratase inhibitor | 0.059 0.027 DBMET01640 | ||
| 0.041 | 0.009 | 0.041 | Calcium-independent phospholipase A2 inhibitor | 0.041 0.009 DBMET01640 | ||
| 0.052 | 0.02 | 0.052 | Histone deacetylase 8 inhibitor | 0.052 0.02 DBMET01640 | ||
| 0.094 | 0.063 | 0.094 | Bile acid receptor antagonist | 0.094 0.063 DBMET01640 | ||
| 0.076 | 0.044 | 0.076 | Phosphofructokinase-1 inhibitor | 0.076 0.044 DBMET01640 | ||
| 0.075 | 0.043 | 0.075 | Prostaglandin-E synthase inhibitor | 0.075 0.043 DBMET01640 | ||
| 0.054 | 0.023 | 0.054 | Adenylate cyclase 1 inhibitor | 0.054 0.023 DBMET01640 | ||
| 0.071 | 0.041 | 0.071 | Exportin-1 inhibitor | 0.071 0.041 DBMET01640 | ||
| 0.054 | 0.025 | 0.054 | Glucose-6-phosphate isomerase inhibitor | 0.054 0.025 DBMET01640 | ||
| 0.143 | 0.114 | 0.143 | 3C-like protease (Human coronavirus) inhibitor | 0.143 0.114 DBMET01640 | ||
| 0.124 | 0.096 | 0.124 | Farnesoid X receptor antagonist | 0.124 0.096 DBMET01640 | ||
| 0.073 | 0.046 | 0.073 | Peroxisome proliferator-activated receptor gamma antagonist | 0.073 0.046 DBMET01640 | ||
| 0.084 | 0.058 | 0.084 | D-Ala-D-Ala ligase inhibitor | 0.084 0.058 DBMET01640 | ||
| 0.094 | 0.068 | 0.094 | UDP-glucose 4-epimerase inhibitor | 0.094 0.068 DBMET01640 | ||
| 0.076 | 0.051 | 0.076 | Porphobilinogen synthase inhibitor | 0.076 0.051 DBMET01640 | ||
| 0.112 | 0.086 | 0.112 | Alpha-N-acetylglucosaminidase inhibitor | 0.112 0.086 DBMET01640 | ||
| 0.156 | 0.131 | 0.156 | Aryl hydrocarbon receptor agonist | 0.156 0.131 DBMET01640 | ||
| 0.106 | 0.082 | 0.106 | Caspase 3 inhibitor | 0.106 0.082 DBMET01640 | ||
| 0.055 | 0.033 | 0.055 | Heparanase inhibitor | 0.055 0.033 DBMET01640 | ||
| 0.088 | 0.068 | 0.088 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.088 0.068 DBMET01640 | ||
| 0.028 | 0.01 | 0.028 | Prostaglandin F2 alpha agonist | 0.028 0.01 DBMET01640 | ||
| 0.055 | 0.037 | 0.055 | Thromboxane synthase inhibitor | 0.055 0.037 DBMET01640 | ||
| 0.071 | 0.054 | 0.071 | CDC25A inhibitor | 0.071 0.054 DBMET01640 | ||
| 0.028 | 0.012 | 0.028 | CYP24 inhibitor | 0.028 0.012 DBMET01640 | ||
| 0.051 | 0.035 | 0.051 | Estrogen agonist | 0.051 0.035 DBMET01640 | ||
| 0.042 | 0.027 | 0.042 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.042 0.027 DBMET01640 | ||
| 0.063 | 0.047 | 0.063 | Protease 3C (Human rhinovirus) inhibitor | 0.063 0.047 DBMET01640 | ||
| 0.084 | 0.069 | 0.084 | Triose-phosphate isomerase inhibitor | 0.084 0.069 DBMET01640 | ||
| 0.059 | 0.045 | 0.059 | Purinergic P2X1 antagonist | 0.059 0.045 DBMET01640 | ||
| 0.11 | 0.096 | 0.11 | DNA repair enzyme inhibitor | 0.11 0.096 DBMET01640 | ||
| 0.038 | 0.026 | 0.038 | Vanilloid 3 antagonist | 0.038 0.026 DBMET01640 | ||
| 0.035 | 0.022 | 0.035 | Tubulin agonist | 0.035 0.022 DBMET01640 | ||
| 0.071 | 0.059 | 0.071 | Na+ K+ transporting ATPase inhibitor | 0.071 0.059 DBMET01640 | ||
| 0.032 | 0.02 | 0.032 | Prostaglandin agonist | 0.032 0.02 DBMET01640 | ||
| 0.058 | 0.047 | 0.058 | Enoyl-[acyl-carrier-protein] reductase inhibitor | 0.058 0.047 DBMET01640 | ||
| 0.08 | 0.069 | 0.08 | mTOR complex 2 inhibitor | 0.08 0.069 DBMET01640 | ||
| 0.068 | 0.058 | 0.068 | Glycine receptor agonist | 0.068 0.058 DBMET01640 | ||
| 0.033 | 0.023 | 0.033 | Histone deacetylase 5 inhibitor | 0.033 0.023 DBMET01640 | ||
| 0.045 | 0.035 | 0.045 | Potassium channel Kv1.3 blocker | 0.045 0.035 DBMET01640 | ||
| 0.061 | 0.052 | 0.061 | Calcium channel P-type blocker | 0.061 0.052 DBMET01640 | ||
| 0.031 | 0.023 | 0.031 | ATP citrate lysase inhibitor | 0.031 0.023 DBMET01640 | ||
| 0.037 | 0.029 | 0.037 | Glutamate (mGluR8) agonist | 0.037 0.029 DBMET01640 | ||
| 0.091 | 0.084 | 0.091 | Adenylate kinase inhibitor | 0.091 0.084 DBMET01640 | ||
| 0.089 | 0.082 | 0.089 | Falcipain 3 inhibitor | 0.089 0.082 DBMET01640 | ||
| 0.116 | 0.108 | 0.116 | Sphingosine 1-phosphate receptor 2 antagonist | 0.116 0.108 DBMET01640 | ||
| 0.033 | 0.026 | 0.033 | HMG CoA reductase inhibitor | 0.033 0.026 DBMET01640 | ||
| 0.059 | 0.053 | 0.059 | CDC25B inhibitor | 0.059 0.053 DBMET01640 | ||
| 0.067 | 0.061 | 0.067 | Glutamate dehydrogenase inhibitor | 0.067 0.061 DBMET01640 | ||
| 0.108 | 0.102 | 0.108 | Antibacterial (Helicobacter pylori) | 0.108 0.102 DBMET01640 | ||
| 0.051 | 0.045 | 0.051 | Beta 1 adrenoreceptor antagonist | 0.051 0.045 DBMET01640 | ||
| 0.08 | 0.075 | 0.08 | NADH dehydrogenase inhibitor | 0.08 0.075 DBMET01640 | ||
| 0.05 | 0.046 | 0.05 | Alcohol oxidase inhibitor | 0.05 0.046 DBMET01640 | ||
| 0.055 | 0.051 | 0.055 | TRPA1 antagonist | 0.055 0.051 DBMET01640 | ||
| 0.052 | 0.049 | 0.052 | Prostaglandin EP2 antagonist | 0.052 0.049 DBMET01640 | ||
| 0.029 | 0.027 | 0.029 | Estrogen-related receptor alpha antagonist | 0.029 0.027 DBMET01640 | ||
| 0.03 | 0.028 | 0.03 | Fumarate hydratase inhibitor | 0.03 0.028 DBMET01640 | ||
| 0.059 | 0.057 | 0.059 | Neuraminidase (influenza) inhibitor | 0.059 0.057 DBMET01640 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |